Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

339 Views

A6. New drug development (formerly L3)

Poster Session: New Drug Development

(P-1055) **Anti-Toxin B Neutralizing Monoclonal Antibody AZD5148 Provides Protection in a Clostridioides difficile Gnotobiotic Piglet Model**

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

DD

Denise Dayao, DVM, PhD

Tufts University
North Grafton, Massachusetts, United States
DG

Donald Girouard, MS

Tufts University
North Grafton, Massachusetts, United States
VG

Victoria Godfrey, MS

AstraZeneca
Gaithersburg, Maryland, United States
AG

Adam Gamson, MS

scientist
Astra Zeneca
Gaithersburg, Maryland, United States
AS

Ann Marie Stanley, PhD

Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Gaithersburg, Maryland, United States
OS

Oleg Stepanov, MS

AstraZeneca
Cambridge, England, United Kingdom
AD

Antonio DiGiandomenico, PhD

Astra Zeneca
Gaithersburg, Maryland, United States
Bret R. Sellman, PhD

Executive Director
AstraZeneca
Gaithersburg, Maryland, United States
ST

Saul Tzipori, DVM, PhD

Tufts University
North Grafton, Massachusetts, United States